These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 12735336)

  • 1. The first example of an HLA-Bw45 antiserum produced in a HLA-Bw44 positive woman.
    Darke C
    Tissue Antigens; 1980 Jan; 15(1):75-80. PubMed ID: 12735336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HLA-B12 and -B40 cross-reactive groups and their serological relationships.
    Darke C
    Tissue Antigens; 1983 Apr; 21(4):281-95. PubMed ID: 6190263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allelic subdivisions of the HLA-B12-Bw21 complex: association with Bw4 and Bw6.
    Mittal KK
    Vox Sang; 1980; 38(5):241-9. PubMed ID: 7415070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of HLA antibody cytotoxicity by intravenous immunoglobulin G F(ab')2 dimers, monomers, and monovalent F(ab).
    Mahoney RJ; Breggia AE
    Hum Immunol; 1999 Jun; 60(6):492-9. PubMed ID: 10408798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of responder cell activity in mixed leukocyte culture reactions. I. Evidence of cross-reactivity of B7-antibody with HLA-B8.
    de Rooij-Doyer E; Bruning JW; van Rood JJ
    Tissue Antigens; 1981 Sep; 18(3):154-65. PubMed ID: 7336421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA antigens of platelets. IV. Influence of "private" HLA--B locus specificities on the expression of Bw4 and Bw6 on human platelets.
    Szatkowski NS; Aster RH
    Tissue Antigens; 1980 Apr; 15(4):361-8. PubMed ID: 7466777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and cellular identification of HLA-Bw44 subtypes.
    Hahn AW; Schendel DJ; Hansen PW; Ploegh HL
    Hum Immunol; 1984 Oct; 11(2):69-76. PubMed ID: 6333415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two subgroups of HLA Bw44 defined by cell-mediated lympholysis that differ in Bw44 expression on platelets and in patterns of genetic linkage disequilibrium.
    Tekolf WA; Biddison WE; Aster RD; Shaw S
    J Immunol; 1982 Oct; 129(4):1474-8. PubMed ID: 6180011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a monoclonal anti-Bw4 antibody (Tü109): evidence for similar epitopes on the Bw4 and Bw6 antigens.
    Müller C; Herbst H; Uchanska-Ziegler B; Ziegler A; Schunter F; Steiert I; Muller C; Wernet P
    Hum Immunol; 1985 Dec; 14(4):333-49. PubMed ID: 2416720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of human CML target. HLA-B locus (B12) antigen variants defined by CTL generated between B locus-identical (B12) responder-stimulator pairs.
    Kato S; Iványi P; Lacko E; Breur B; Du Bois R; Eijsvoogel VP
    J Immunol; 1982 Feb; 128(2):949-55. PubMed ID: 6976390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA antigens: rabbit antisera reacting with all A series or all B series specificities.
    Cresswell P; Ayres JL
    Eur J Immunol; 1976 Feb; 6(2):82-8. PubMed ID: 786698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serologic recognition of a HLA-B44(12) subgroup associated with the 44.2 specificity defined by CML.
    Heise ER; Tekolf WA; Hampton JP
    Hum Immunol; 1984 Nov; 11(3):163-71. PubMed ID: 6084000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and serological heterogeneity of the supertypic HLA-B locus specificities Bw4 and Bw6.
    Müller CA; Engler-Blum G; Gekeler V; Steiert I; Weiss E; Schmidt H
    Immunogenetics; 1989; 30(3):200-7. PubMed ID: 2777338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An association study of Huntington's disease and HLA.
    Madsen H; Nielsen LS; Sørensen SA
    J Med Genet; 1982 Dec; 19(6):452-4. PubMed ID: 6218304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cytotoxic monoclonal human hybridoma antibody (TrJ3) against HLA-B44(12) and -B45(12).
    Ge J; Bratlie A; Hannestad K
    Tissue Antigens; 1992 May; 39(5):258-61. PubMed ID: 1384167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional structural modelling and calculation of electrostatic potentials of HLA Bw4 and Bw6 epitopes to explain the molecular basis for alloantibody binding: toward predicting HLA antigenicity and immunogenicity.
    Mallon DH; Bradley JA; Winn PJ; Taylor CJ; Kosmoliaptsis V
    Transplantation; 2015 Feb; 99(2):385-90. PubMed ID: 25606786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supertypic HLA-Bw4 antigen detected by a new monoclonal antibody.
    Rychlíková M; Hinzová E; Nosek J; Forejt J
    Exp Clin Immunogenet; 1986; 3(2):88-97. PubMed ID: 3274050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A F(ab')2 fragment blocking study of the HLA-B14 antigen.
    Darke C
    Tissue Antigens; 1985 Apr; 25(4):177-86. PubMed ID: 2409633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological analysis of xenogeneic anti-lymphoblastoid cell-line sera with specificity against HLA-B12.
    Schäfer K; Albert ED; Rodt H; Thierfelder S
    Immunogenetics; 1980; 10(6):595-602. PubMed ID: 22457938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bw4-reactive and Bw6-reactive antibodies recognize multiple distinct HLA structures that partially overlap in the alpha-1 helix.
    Lutz CT; Smith KD; Greazel NS; Mace BE; Jensen DA; McCutcheon JA; Goeken NE
    J Immunol; 1994 Nov; 153(9):4099-110. PubMed ID: 7523516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.